Initial Choice of Oral Glucose-Lowering Medication for Diabetes Mellitus | Zendy

Seth A. Berkowitz | Zendy; Alexis A. Krumme | Zendy; Jerry Avorn | Zendy; Troyen A. Brennan | Zendy; Olga S. Matlin | Zendy; Claire M. Spettell | Zendy; Edmund J. Pezalla | Zendy; Gregory Brill | Zendy; William H. Shrank | Zendy; Niteesh K. Choudhry | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Initial Choice of Oral Glucose-Lowering Medication for Diabetes Mellitus

Author(s) -

Seth A. Berkowitz,

Alexis A. Krumme,

Jerry Avorn,

Troyen A. Brennan,

Olga S. Matlin,

Claire M. Spettell,

Edmund J. Pezalla,

Gregory Brill,

William H. Shrank,

Niteesh K. Choudhry

Publication year - 2014

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2014.5294

Subject(s) - medicine , metformin , diabetes mellitus , sulfonylurea , medical prescription , hypoglycemia , thiazolidinedione , insulin , adverse effect , dipeptidyl peptidase 4 inhibitor , propensity score matching , type 2 diabetes mellitus , type 2 diabetes , endocrinology , pharmacology

Although many classes of oral glucose-lowering medications have been approved for use, little comparative effectiveness evidence exists to guide initial selection of therapy for diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research